Cramer's Morning Take: Eli Lilly & Salesforce 2/27/24
b'Jim Cramer discusses the Club\\u2019s recommendation to buy Eli Lilly. Cramer also says there\\u2019s a \\u2018red flag\\u2019 for Salesforce ahead of earnings. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market\\u2019s biggest headlines. Signup here: cnbc.com/morningtake \\nCNBC Investing Club Disclaimer'